Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Boyer

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Developments in Biological Standardization|December 17, 1998
HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL responseJ D Boyer, M Chattergoon, A Shah, et al.
The Journal of Infectious Diseases|December 23, 1999
Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up dataR R MacGregor, J D Boyer, R B Ciccarelli, et al.
Journal of Leukocyte Biology|August 27, 2014
High IP-10 levels decrease T cell function in HIV-1-infected individuals on ARTL A Ramirez, T A Arango, E Thompson, et al.
International Journal for Parasitology|April 12, 2002
IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaquesJ D Boyer, B Nath, K Schumann, et al.
DNA and Cell Biology|October 1, 1993
Genetic infection induces protective in vivo immune responsesW V Williams, J D Boyer, M Merva, et al.
Journal of Virology|December 16, 1998
In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse modelJ I Sin, J J Kim, J D Boyer, et al.
Vaccine|June 1, 1997
Development of a multicomponent candidate vaccine for HIV-1J J Kim, V Ayyavoo, M L Bagarazzi, et al.
Immunologic Research|January 1, 1994
Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculationW V Williams, Q Fang, J M Von Feldt, et al.
Journal of Liposome Research|February 27, 2003
Next generation DNA vaccines for HIV-1J D Boyer, Michael Chattergoon, Karuppiah Muthumani, et al.
Developments in Biologicals|November 21, 2001
Engineering of DNA vaccines using molecular adjuvant plasmidsJ I Sin, J Kim, M Chattergoon, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Developments in Biological Standardization|December 17, 1998
HIV-1 DNA based vaccine induces a CD8 mediated cross-clade CTL responseJ D Boyer, M Chattergoon, A Shah, et al.
The Journal of Infectious Diseases|December 23, 1999
Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up dataR R MacGregor, J D Boyer, R B Ciccarelli, et al.
Journal of Leukocyte Biology|August 27, 2014
High IP-10 levels decrease T cell function in HIV-1-infected individuals on ARTL A Ramirez, T A Arango, E Thompson, et al.
International Journal for Parasitology|April 12, 2002
IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaquesJ D Boyer, B Nath, K Schumann, et al.
DNA and Cell Biology|October 1, 1993
Genetic infection induces protective in vivo immune responsesW V Williams, J D Boyer, M Merva, et al.
Journal of Virology|December 16, 1998
In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse modelJ I Sin, J J Kim, J D Boyer, et al.
Vaccine|June 1, 1997
Development of a multicomponent candidate vaccine for HIV-1J J Kim, V Ayyavoo, M L Bagarazzi, et al.
Immunologic Research|January 1, 1994
Immunotherapeutic strategies targeting rheumatoid synovial T-cell receptors by DNA inoculationW V Williams, Q Fang, J M Von Feldt, et al.
Journal of Liposome Research|February 27, 2003
Next generation DNA vaccines for HIV-1J D Boyer, Michael Chattergoon, Karuppiah Muthumani, et al.
Developments in Biologicals|November 21, 2001
Engineering of DNA vaccines using molecular adjuvant plasmidsJ I Sin, J Kim, M Chattergoon, et al.
Pageof 5